BioNexus Gene Lab (BGLC) Current Deferred Revenue (2021 - 2026)
BioNexus Gene Lab (BGLC) posted Current Deferred Revenue of $8416.0 for Q1 2026, little changed sequentially from $8385.0 in Q4 2025, and down 61.68% YoY from $21964.0 in Q1 2025.
BioNexus Gene Lab (BGLC) Current Deferred Revenue (2021 - 2026) Analysis & Trends
BioNexus Gene Lab has reported Current Deferred Revenue for 6 years, with the latest figure at $8416.0 in Q1 2026.
- Quarterly Current Deferred Revenue fell 61.68% year-over-year to $8416.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8416.0 (down 61.68% YoY) and the FY2025 annual result came in at $8385.0, down 91.25% from the prior year.
- Current Deferred Revenue was little changed at $8416.0 in Q1 2026 per BGLC's latest filing, from $8385.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $95879.0 in Q4 2024 and troughed at $107.0 in Q1 2022.
- A 5-year average of $18453.2 and a median of $11264.0 in 2025 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2023 and 2025: Current Deferred Revenue jumped 14219.63% in 2023, then tumbled 91.25% in 2025.
- Over 5 years, Current Deferred Revenue stood at $23123.0 in 2022, then slumped by 64.46% to $8218.0 in 2023, then jumped by 1066.7% to $95879.0 in 2024, then sank by 91.25% to $8385.0 in 2025, then gained by 0.37% to $8416.0 in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $8416.0, $8385.0, and $11264.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 225.78 Bn | 220.88 Bn | 4.43 Bn |
| 2 | Sherwin Williams | 84.85 Bn | 84.56 Bn | 3.34 Bn |
| 3 | Ecolab | 78.88 Bn | 73.74 Bn | 1.95 Bn |
| 4 | Air Products & Chemicals | 68.32 Bn | 67.34 Bn | 1.04 Bn |
| 5 | Ppg Industries | 25.34 Bn | 23.75 Bn | 1.81 Bn |
| 6 | Chemical & Mining Co Of Chile | 23.48 Bn | 19.61 Bn | 778.60 Mn |
| 7 | LyondellBasell Industries | 21.90 Bn | 19.27 Bn | 2.04 Bn |
| 8 | International Flavors & Fragrances | 21.49 Bn | 20.92 Bn | 853.00 Mn |
| 9 | DuPont de Nemours | 18.82 Bn | 17.08 Bn | 639.00 Mn |
| 10 | BioNexus Gene Lab | 2.28 Mn | -1.25 Mn | 12,982.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,416.00 |
| Dec 31, 2025 | 8,385.00 |
| Sep 30, 2025 | 11,264.00 |
| Jun 30, 2025 | 11,348.00 |
| Mar 31, 2025 | 21,964.00 |
| Dec 31, 2024 | 95,879.00 |
| Sep 30, 2024 | 22,834.00 |
| Jun 30, 2024 | 5,937.00 |
| Sep 30, 2023 | 8,218.00 |
| Jun 30, 2023 | 7,094.00 |
| Mar 31, 2023 | 15,322.00 |
| Dec 31, 2022 | 23,123.00 |
| Mar 31, 2022 | 107.00 |
| Dec 31, 2021 | 77,276.00 |